Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Rinner, B; Froehlich, EV; Buerger, K; Knausz, H; Lohberger, B; Scheipl, S; Fischer, C; Leithner, A; Guelly, C; Trajanoski, S; Szuhai, K; Liegl, B.
Establishment and detailed functional and molecular genetic characterisation of a novel sacral chordoma cell line, MUG-Chor1.
Int J Oncol. 2012; 40(2): 443-451. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG


Autor/innen der Med Uni Graz:
Fischer Carina
Fröhlich-Sorger Elke
Gülly Christian
Knausz Heike
Leithner Andreas
Liegl-Atzwanger Bernadette
Lohberger Birgit
Rinner Beate
Scheipl Susanne
Trajanoski Slave

Dimensions Citations:

Plum Analytics:
Chordomas are rare, low to intermediate grade malignant bone tumors of the axial skeleton. Current treatment options are limited to surgical procedures, as chordomas are largely resistant to conventional radiation and chemotherapy. Cell lines are valuable tools for exploring molecular mechan-isms involved in tumorigenesis and they have a fundamental impact on the development of new anticancer agents. To date, only two chordoma cell lines exist world-wide. In the present study we report a third chordoma cell line, MUG-Chor1, as well as corresponding cultured fibroblasts established from a recur-rent morphologically 'classic' sacrococcygeal chordoma of a 58-year-old Caucasian female. The cells are brachyury-positive and have the characteristics of chordoma. The genetic profile of the primary chordoma and the established chordoma cell line was investigated during the culturing period (early and late passage). MUG-Chor1 is karyotypically, <2n>43-47,XX,del(3)(q1?)[11], +7,del(9)(p1?),der(9;15)(q10;q10),-10,+der(12)t(9;12)(p2?;q1?),der (12)t(12;19)(p;p)t(17;19)(q;q),-15,der(17;21)(q10;q10),der(20)t(10;20) (q25?26?;q11?12?),-21,-22[20]/idemx2[5] and displays known, chordoma-typical genetic changes, such as chromosomal gains at T/brachyury locus (6q27), losses at 9p24.3-p13.1 (includes the CDKN2a/CDKN2b locus), 10p15.3-q23.32 (includes the PTEN locus) and losses of 10q25.2 (includes the PDCD4 locus). MUG-Chor1 bears a marked resemblance to chordomas in vivo and is, therefore, an optimal in vitro chordoma model.
Find related publications in this database (using NLM MeSH Indexing)
Cell Line, Tumor - enzymology
Chordoma - genetics
Coccyx - pathology
Female -
Gene Dosage -
Genotype -
Humans -
Karyotype -
Loss of Heterozygosity -
Middle Aged -
Oligonucleotide Array Sequence Analysis -
Polymorphism, Single Nucleotide -
Sacrum - pathology
Spinal Neoplasms - genetics
Tumor Markers, Biological - genetics

Find related publications in this database (Keywords)
cell line
matrix metalloproteinases
© Med Uni Graz Impressum